Company intelligence / Profile preview
G&E Herbal Biotechnology
- Ownership
- Private
- Development stage
- Other
Overview
G&E Herbal Biotechnology is developing botanical drugs using proprietary extraction technology. Its lead programs include SR-T100 Gel for actinic keratoses/genital warts and Apocin Capsule for lung cancer. The company’s pipeline spans preclinical to clinical stages with ongoing trials at major medical centers targeting oncology and dermatology indications. No approved drugs yet reported as of June 2025.
- Therapeutic areas
- GastroenterologyMen's HealthNephrologyDermatologyOncology
- Modalities
- Herbal medicineSmall molecule drug
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on G&E Herbal Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G&E Herbal Biotechnology.